UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005336
Receipt No. R000006249
Scientific Title A phase I/II study of S-1+Irinotecan+panitumumab as first line treatment to advanced colorectal cancer
Date of disclosure of the study information 2011/04/01
Last modified on 2016/10/06 15:30:47

No. Disposal Last modified on Item of update
1 Insert 2011/03/29 14:33:25
2 Update 2011/04/01 12:24:52 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
3 Update 2012/03/30 10:07:08 Post marketing survey by drug manufacture etc., specified by Japanese law.
Institutions
4 Update 2012/03/30 10:08:27 Recruitment status
5 Update 2012/10/02 14:25:11 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
6 Update 2012/10/02 14:28:23 Last name of lead principal investigator
Email
Name of person sending information
Name of person sending information
Organization
Organization
Address
7 Update 2013/04/02 15:35:36 Email
8 Update 2013/09/30 14:13:42 Email
9 Update 2014/04/11 12:12:45 Last follow-up date
10 Update 2014/10/06 13:10:08 Last follow-up date
11 Update 2015/01/08 13:50:53 Name of person sending information
Name of person sending information
12 Update 2015/01/08 13:51:31 Recruitment status
13 Update 2016/02/25 10:50:09 Organization
Organization
Division name
Division name
Address
Address
TEL
14 Update 2016/10/06 15:30:47 Recruitment status
Results
Other related information


Contact us.